Page 339 - Read Online

Egresi et al. NAFLD and gut dysbiosis

2. Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. 12. Zhang X, Osaka T, Tsuneda S. Bacterial metabolites directly modulate
Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic farnesoid X receptor activity. Nutr Metab (Lond) 2015;12:48.
steatohepatitis: a systematic review and meta-analysis of paired-biopsy 13. Paolella G, Mandato C, Pierri L, Poeta M, Di Stasi M, Vajro P. Gut-
studies. Clin Gastroenterol Hepatol 2015;13:643-54.e1-9; quiz e39-40. liver axis and probiotics: their role in non-alcoholic fatty liver disease.
3. Boursier J, Diehl AM. Nonalcoholic fatty liver disease and the gut World J Gastroenterol 2014;20:15518-31.
microbiome. Clin Liver Dis 2016;20:263-75. 14. Haque TR, Barritt ASt. Intestinal microbiota in liver disease. Best
4. Xie G, Wang X, Liu P, Wei R, Chen W, Rajani C, Hernandez BY, Pract Res Clin Gastroenterol 2016;30:133-42.
Alegado R, Dong B, Li D, Jia W. Distinctly altered gut microbiota in 15. Dugan CE, Aguilar D, Park YK, Lee JY, Fernandez ML. Dairy
the progression of liver disease. Oncotarget 2016;7:19355-66. consumption lowers systemic inflammation and liver enzymes in
5. Yu J, Marsh S, Hu J, Feng W, Wu C. The pathogenesis of nonalcoholic typically low-dairy consumers with clinical characteristics of metabolic
fatty liver disease: interplay between diet, gut microbiota, and genetic syndrome. J Am Coll Nutr 2016;35:255-61.
background. Gastroenterol Res Pract 2016;2016:2862173. 16. Imani Fooladi AA, Mahmoodzadeh Hosseini H, Nourani MR, Khani
6. Nabavi S, Rafraf M, Somi MH, Homayouni-Rad A, Asghari- S, Alavian SM: Probiotic as a novel treatment strategy against liver
Jafarabadi M. Effects of probiotic yogurt consumption on metabolic disease. Hepat Mon 2013;13:e7521.
factors in individuals with nonalcoholic fatty liver disease. J Dairy Sci 17. Liu JE, Zhang Y, Zhang J, Dong PL, Chen M, Duan ZP. Probiotic
2014;97:7386-93.
7. Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo- yogurt effects on intestinal flora of patients with chronic liver disease.
Perez F, Guy CD, Seed PC, Rawls JF, David LA, Hunault G, Oberti F, Nurs Res 2010;59:426-32.
Calès P, Diehl AM. The severity of nonalcoholic fatty liver disease is 18. Takahashi Y, Sugimoto K, Inui H, Fukusato T. Current
associated with gut dysbiosis and shift in the metabolic function of the pharmacological therapies for nonalcoholic fatty liver disease/
gut microbiota. Hepatology 2016;63:764-75. nonalcoholic steatohepatitis. World J Gastroenterol 2015;21:3777-85.
8. Dvorak K, Stritesky J, Petrtyl J, Vitek L, Sroubkova R, Lenicek M, 19. Saez-Lara MJ, Robles-Sanchez C, Ruiz-Ojeda FJ, Plaza-Diaz J, Gil
Smid V, Haluzik M, Bruha R. Use of non-invasive parameters of A. Effects of probiotics and synbiotics on obesity, insulin resistance
non-alcoholic steatohepatitis and liver fibrosis in daily practice - an syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a
exploratory case-control study. PLoS One 2014;9:e111551. review of human clinical trials. Int J Mol Sci 2016;17:E928.
9. Ferraioli G, Tinelli C, Lissandrin R, Zicchetti M, Dal Bello B, Filice G, 20. Shavakhi A, Minakari M, Firouzian H, Assali R, Hekmatdoost A,
Filice C. Controlled attenuation parameter for evaluating liver steatosis Ferns G. Effect of a probiotic and metformin on liver aminotransferases
in chronic viral hepatitis. World J Gastroenterol 2014;20:6626-31. in non-alcoholic steatohepatitis: a double blind randomized clinical
10. Fitzpatrick E, Dhawan A. Noninvasive biomarkers in non-alcoholic trial. Int J Prev Med 2013;4:531-7.
fatty liver disease: current status and a glimpse of the future. World J 21. Mei L, Tang Y, Li M, Yang P, Liu Z, Yuan J, Zheng P. Co-
Gastroenterol 2014;20:10851-63. administration of cholesterol-lowering probiotics and anthraquinone
11. Nalbantoglu IL, Brunt EM. Role of liver biopsy in nonalcoholic fatty from Cassia obtusifolia L. ameliorate non-alcoholic fatty liver. PLoS
liver disease. World J Gastroenterol 2014;20:9026-37. One 2015;10:e0138078.

330 Hepatoma Research ¦ Volume 2 ¦ December 13, 2016